Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245.6 EUR | -0.14% | -.--% | -.--% |
11:49am | Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial | MT |
09:57am | Roche: positive phase III results in MS | CF |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock
- Revisions Roche Holding AG